1. Research Progress and Future Development Potential of Oridonin in Pharmacological Activities
   Jinhuan Jiang et al, 2023, Current Molecular Pharmacology CrossRef
2. Oridonin inhibits migration, invasion, adhesion and TGF‑β1‑induced epithelial‑mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK‑3β signaling pathway
   Chun‑Yu Li et al, 2017, Oncology Letters CrossRef
3. Differential proteomics for studying action mechanisms of traditional Chinese medicines
   Yi-Yao Yang et al, 2019, Chinese Medicine CrossRef
4. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
   Hua Luo et al, 2019, Chinese Medicine CrossRef
5. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers
   Xin Leng et al, 2018, Molecules CrossRef
6. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
   Xiang Li et al, 2021, Frontiers in Pharmacology CrossRef
7. Zirconium‐Porphyrin PCN‐222: pH‐responsive Controlled Anticancer Drug Oridonin
   Xin Leng et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1
   Xiaojun Zhang et al, 2023, Molecules CrossRef